TCL Archive Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm September 9, 2011
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan June 10, 1988
TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
